OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 317
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 317
Showing 1-25 of 317 citing articles:
Stimuli-responsive ferroptosis for cancer therapy
Nayeon Kang, Subin Son, Sun-Hong Min, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 12, pp. 3955-3972
Closed Access | Times Cited: 111
Nayeon Kang, Subin Son, Sun-Hong Min, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 12, pp. 3955-3972
Closed Access | Times Cited: 111
Aggregation-induced emission photosensitizer-based photodynamic therapy in cancer: from chemical to clinical
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Zijuan Meng, Huiying Xue, Tingting Wang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Advances in the structure, mechanism and targeting of chemoresistance-linked ABC transporters
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 69
Andaleeb Sajid, Hadiar Rahman, Suresh V. Ambudkar
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 762-779
Closed Access | Times Cited: 69
Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazim Nasir, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123276-123276
Closed Access | Times Cited: 43
Mohammad Sameer Khan, B.H. Jaswanth Gowda, Nazim Nasir, et al.
International Journal of Pharmaceutics (2023) Vol. 643, pp. 123276-123276
Closed Access | Times Cited: 43
Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 25
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 25
Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine
Ying Bao, Dejing Zhang, Huihui� Guo, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 15
Ying Bao, Dejing Zhang, Huihui� Guo, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1060-1072
Open Access | Times Cited: 15
Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 13
Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 680-680
Open Access | Times Cited: 13
Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 1
Xinyue Shao, Xiaoling Zhao, Binghao Wang, et al.
Theranostics (2025) Vol. 15, Iss. 5, pp. 1689-1714
Open Access | Times Cited: 1
Curcumin-Based Nanoparticles: Advancements and Challenges in Tumor Therapy
Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 114-114
Open Access | Times Cited: 1
Hicham Wahnou, Riad El Kebbaj, Bertrand Liagre, et al.
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 114-114
Open Access | Times Cited: 1
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 34
MiRNA-93: a novel signature in human disorders and drug resistance
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Mohammed Fatih Rasul, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Mohammed Fatih Rasul, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 25
Current scenario of pyrazole hybrids with in vivo therapeutic potential against cancers
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 25
Zhi Xu, Yafei Zhuang, Qingtai Chen
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115495-115495
Closed Access | Times Cited: 25
Dendrimers: Advancements and Potential Applications in Cancer Diagnosis and Treatment—An Overview
Andreea Crintea, Alexandru Cătălin Motofelea, Alina Simona Șovrea, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1406-1406
Open Access | Times Cited: 23
Andreea Crintea, Alexandru Cătălin Motofelea, Alina Simona Șovrea, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1406-1406
Open Access | Times Cited: 23
Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A Review
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Eugenio Sánchez-Arreola
Biomedicines (2023) Vol. 11, Iss. 2, pp. 389-389
Open Access | Times Cited: 21
Jorge L. Mejía-Méndez, Edgar R. López-Mena, Eugenio Sánchez-Arreola
Biomedicines (2023) Vol. 11, Iss. 2, pp. 389-389
Open Access | Times Cited: 21
Design, synthesis and bioactivity study on oxygen-heterocyclic-based pyran analogues as effective P-glycoprotein-mediated multidrug resistance in MCF-7/ADR cell
Ashraf Hassan Fekry Abd El‐Wahab, Rita M. Borik, Al-Anood M. Al-Dies, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Ashraf Hassan Fekry Abd El‐Wahab, Rita M. Borik, Al-Anood M. Al-Dies, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 10
Targeting of TAMs: can we be more clever than cancer cells?
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 9
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 9
Natural products reverse cancer multidrug resistance
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Jiayu Zou, Qilei Chen, Xiao-Ci Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Natural Compounds and Breast Cancer: Chemo-Preventive and Therapeutic Capabilities of Chlorogenic Acid and Cinnamaldehyde
Yusuff Olayiwola, Lauren Gollahon
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 361-361
Open Access | Times Cited: 8
Yusuff Olayiwola, Lauren Gollahon
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 361-361
Open Access | Times Cited: 8
A comprehensive review of computational cell cycle models in guiding cancer treatment strategies
Chenhui Ma, Evren Gürkan-Çavusoglu
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Chenhui Ma, Evren Gürkan-Çavusoglu
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 8
Organoids: An Emerging Precision Medicine Model for Prostate Cancer Research
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 7
Mohammad Waseem, Bi‐Dar Wang
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1093-1093
Open Access | Times Cited: 7
The Potential Harmful Effects of Genetically Engineered Microorganisms (GEMs) on the Intestinal Microbiome and Public Health
Aaron Lerner, Carina Benzvi, Aristo Vojdani
Microorganisms (2024) Vol. 12, Iss. 2, pp. 238-238
Open Access | Times Cited: 7
Aaron Lerner, Carina Benzvi, Aristo Vojdani
Microorganisms (2024) Vol. 12, Iss. 2, pp. 238-238
Open Access | Times Cited: 7
Revolutionizing in vivo therapy with CRISPR/Cas genome editing: breakthroughs, opportunities and challenges
Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 7
Arturo Macarrón Palacios, Patrick Korus, Bodo G. C. Wilkens, et al.
Frontiers in Genome Editing (2024) Vol. 6
Open Access | Times Cited: 7
Targeting PI3K/AKT/mTOR Signaling to Overcome Drug Resistance in Cancer
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 7
Muhammad Tufail, Wendong Wan, Canhua Jiang, et al.
Chemico-Biological Interactions (2024) Vol. 396, pp. 111055-111055
Closed Access | Times Cited: 7
Drug Delivery Nano-Platforms for Advanced Cancer Therapy
Ekaterina Naumenko, Ivan Guryanov, Marina Gomzikova
Scientia Pharmaceutica (2024) Vol. 92, Iss. 2, pp. 28-28
Open Access | Times Cited: 7
Ekaterina Naumenko, Ivan Guryanov, Marina Gomzikova
Scientia Pharmaceutica (2024) Vol. 92, Iss. 2, pp. 28-28
Open Access | Times Cited: 7
Permeability Benchmarking: Guidelines for Comparing in Silico, in Vitro, and in Vivo Measurements
Christian Jorgensen, Raleigh M. Linville, Ian Galea, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Christian Jorgensen, Raleigh M. Linville, Ian Galea, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
